Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: The Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study (vol 26, pg 855, 2004)

被引：0
|
作者：
Malacco, E
机构：
来源：
CLINICAL THERAPEUTICS | 2004年 / 26卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1185 / 1185
页数：1
相关论文
共 11 条
  • [1] Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) study (vol 26, pg 855, 2004)
    Malacco, E
    CLINICAL THERAPEUTICS, 2005, 27 (01) : 142 - 142
  • [2] Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension:: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) study
    Malacco, E
    Santonastaso, M
    Varì, NA
    Gargiulo, A
    Spagnuolo, V
    Bertocchi, F
    Palatini, P
    Fogari, R
    Perna, GP
    Paci, MV
    di Ancona, T
    Arnaldi, G
    Boscaro, M
    Pedace, C
    Moretti, L
    Piceno, A
    Pinna, G
    Rosato, G
    Maina, M
    Baldini, A
    Chimini, C
    Proto, C
    Destro, M
    Maxia, P
    Meloni, L
    Vaccarella, A
    Gargiulo, A
    Ronchi, E
    Cannone, M
    Olivieri, L
    Rossi, A
    Turchetti, CG
    Sprovieri, M
    Ansuini, R
    Gruppillo, P
    Caiazza, A
    Di Taranto, A
    Aquilina, M
    Costa, PL
    Santilli, E
    Zecca, A
    Percio, E
    Dassi, S
    Grechi, P
    Sommariva, D
    Santucci, A
    Tascione, E
    Magliari, E
    Locatelli, F
    Rigatelli, F
    CLINICAL THERAPEUTICS, 2004, 26 (06) : 855 - 865
  • [3] Valsartan versus lisinopril for the treatment of hypertension: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) study
    Palatini, P
    Malacco, E
    JOURNAL OF HYPERTENSION, 2004, 22 : S384 - S384
  • [4] Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy
    Johannes Brachmann
    Anwar Ansari
    Gerhard Mahla
    Renate Handrock
    Sven Klebs
    Advances in Therapy, 2008, 25 : 399 - 411
  • [5] Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy
    Brachmann, Johannes
    Ansari, Anwar
    Mahla, Gerhard
    Handrock, Renate
    Klebs, Sven
    ADVANCES IN THERAPY, 2008, 25 (05) : 399 - 411
  • [6] The time to blood pressure (BP) control by initiating antihypertensive therapy with a higher dose of valsartan (160mg) or valsartan/hydrochlorothiazide compared to low-dose valsartan (80 mg) in the treatment of hypertension. The Velocity study
    Jamerson, K.
    Zappe, D.
    Daley, W.
    JOURNAL OF HYPERTENSION, 2007, 25 : S239 - S239
  • [7] Intensive blood pressure reduction in patients with increased cardiovascular risk with high-dose combination therapy of 160 mg valsartan plus 25 mg hydrochlorothiazide. Results of the MACHT II observational study
    Schuehlen, Helmut
    Abts, Markus
    Kastrati, Dorejd
    HERZ, 2007, 32 (05) : 419 - 425
  • [8] Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study)
    Palatini, P
    Mugellini, A
    Spagnuolo, V
    Santonastaso, M
    Ambrosio, GB
    Caiazza, A
    Malacco, E
    BLOOD PRESSURE MONITORING, 2004, 9 (02) : 91 - 97
  • [9] Starke Blutdrucksenkung durch hochdosierte Kombinationstherapie von 160 mg Valsartan und 25 mg HCT in der alltäglichen Behandlungspraxis bei Patienten mit erhöhtem kardiovaskulären RisikoErgebnisse der MACHT-II-BeobachtungsstudieIntensive Blood Pressure Reduction in Patients with Increased Cardiovascular Risk with High-Dose Combination Therapy of 160 mg Valsartan plus 25 mg Hydrochlorothiazide. Results of the MACHT II Observational Study
    Helmut Schühlen
    Markus Abts
    Dorejd Kastrati
    Herz Kardiovaskuläre Erkrankungen, 2007, 32 (5) : 419 - 425
  • [10] A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients
    Ding, PYA
    Chu, KM
    Chiang, HT
    Shu, KH
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 : 16 - 22
12